The Rapid COVID-19 Antigen Test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) swab from individuals who are suspected of COVID-19 by their healthcare provider. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections.
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. Currently, individuals infected by SARS-CoV-2 are the main source of transmission; asymptomatic carriers are also known as a source of transmission. Based on the current epidemiological information, the incubation period can last from 1 to 14 days, where the average time before symptoms occur is about 5 days. The Healgen rapid COVID-19 Antigen test has been trialled and tested by Public Health England.
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. Currently, individuals infected by SARS-CoV-2 are the main source of transmission; asymptomatic carriers are also known as a source of transmission. Based on the current epidemiological information, the incubation period can last from 1 to 14 days, where the average time before symptoms occur is about 5 days. The Healgen rapid COVID-19 Antigen test has been trialled and tested by Public Health England.
Features:
- Qualitative, visually read results in 15 minutes.
- No instrument required.
- Room temperature storage or refrigerated (2-30⁰C / 36-86⁰F)
- Procedural internal control included.
- Sterile Swabs, Extraction Buffer.
- Extraction Tubes included.
Specifications:
- Clinical Evaluation
- Positive Percent Agreement (PPA): 97.3%
- Negative Percent Agreement (NPA): 99.6%
- Overall Percent Agreement (OPA): 98.9%
- Specimen: Nasopharyngeal (NP) Swab
- Time to Results: 15 minutes
- Shelf Life: 24 months from the date of manufacture.
